Founders Grove Wealth Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.11M Buy
8,327
+160
+2% +$37.3K 0.42% 54
2026
Q1
$2M Sell
8,167
-67
-0.8% -$15.6K 0.45% 50
2025
Q4
$1.7M Buy
8,234
+954
+13% +$189K 0.38% 56
2025
Q3
$1.35M Buy
7,280
+686
+10% +$118K 0.32% 60
2025
Q2
$1.01M Sell
6,594
-292
-4% -$44.9K 0.25% 70
2025
Q1
$1.14M Buy
6,886
+168
+3% +$26.3K 0.32% 64
2024
Q4
$972K Buy
+6,718
New +$1.04M 0.28% 71

Other funds holding JNJ

Founders Grove Wealth Partners's JNJ Position: Q2 2026 in Review

Founders Grove Wealth Partners increased its Johnson & Johnson (JNJ) stake by 2% in Q2 2026, buying an estimated $37.3K and bringing the position to 8,327 shares worth $2.11M. The position accounts for 0.42% of the portfolio, ranked #54.

Founders Grove Wealth Partners first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Founders Grove Wealth Partners held 8,327 shares of Johnson & Johnson worth $2.11M as of Q2 2026.
  • Founders Grove Wealth Partners bought 160 Johnson & Johnson shares in Q2 2026, an estimated $37.3K.
  • Johnson & Johnson made up 0.42% of Founders Grove Wealth Partners's portfolio in Q2 2026, its #54 holding.
  • Founders Grove Wealth Partners first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Founders Grove Wealth Partners's 13F filing for Q2 2026, filed 22 Jul 2026.